OBLN
Price:
$3.05
Market Cap:
$5.47M
Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallow able capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disp...[Read more]
Industry
Medical - Devices
IPO Date
2016-10-06
Stock Exchange
NASDAQ
Ticker
OBLN
According to Obalon Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.55. This represents a change of -1.25% compared to the average of 1.57 of the last 4 quarters.
The mean historical Current Ratio of Obalon Therapeutics, Inc. over the last ten years is 7.95. The current 1.55 Current Ratio has changed 1.85% with respect to the historical average. Over the past ten years (40 quarters), OBLN's Current Ratio was at its highest in in the March 2017 quarter at 19.19. The Current Ratio was at its lowest in in the September 2015 quarter at 0.
Average
7.95
Median
4.59
Minimum
1.55
Maximum
23.21
Discovering the peaks and valleys of Obalon Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 585.61%
Maximum Annual Current Ratio = 23.21
Minimum Annual Increase = -89.32%
Minimum Annual Current Ratio = 1.55
Year | Current Ratio | Change |
---|---|---|
2020 | 1.55 | -66.14% |
2019 | 4.59 | 175.79% |
2018 | 1.66 | -67.84% |
2017 | 5.17 | -69.59% |
2016 | 17.00 | 585.61% |
2015 | 2.48 | -89.32% |
The current Current Ratio of Obalon Therapeutics, Inc. (OBLN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.60
5-year avg
5.99
10-year avg
7.95
Obalon Therapeutics, Inc.’s Current Ratio is
Company | Current Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Obalon Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Obalon Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Obalon Therapeutics, Inc.'s Current Ratio?
How is the Current Ratio calculated for Obalon Therapeutics, Inc. (OBLN)?
What is the highest Current Ratio for Obalon Therapeutics, Inc. (OBLN)?
What is the 3-year average Current Ratio for Obalon Therapeutics, Inc. (OBLN)?
What is the 5-year average Current Ratio for Obalon Therapeutics, Inc. (OBLN)?
How does the current Current Ratio for Obalon Therapeutics, Inc. (OBLN) compare to its historical average?